期刊文献+

黄芪甲苷抑制高糖腹透液诱导HMrSV5氧化应激与EMT的实验研究 被引量:12

The Effect of Astragaloside-Ⅳ on Oxygen Stress and EMT of HMrSV5 Induced by High-glucose Peritoneal Dialysate
下载PDF
导出
摘要 目的观察黄芪甲苷(AstragalosideⅣ,AS-Ⅳ)对高糖腹透液诱导人腹膜间皮细胞HMrSV5氧化应激及EMT的影响,探讨ROS在EMT中的作用及AS-Ⅳ干预机制。方法采用葡萄糖腹透液诱导建立HMrSV5氧化应激模型,相差显微镜观察细胞形态变化,MTT检测AS-Ⅳ及葡萄糖腹透液对细胞活力的影响;予40μg/mL AS-Ⅳ干预HMrSV5氧化应激,DHE荧光探针检测药物作用前后ROS生成水平变化,Western blot检测EMT相关蛋白变化;与ROS清除剂NAC作对照,观察AS-Ⅳ干预HMrSV5氧化应激EMT指标及Smads蛋白的变化。结果 140、50μg/mL AS-Ⅳ干预后细胞活力稍有上升(P<0.05);随腹透液作用时间的延长及葡萄糖浓度提高,细胞活力明显抑制,以4.25%高糖腹透液干预48h最明显(P<0.05),细胞拉伸变长;240μg/mL AS-Ⅳ作用细胞能抑制形态改变,降低模型组ROS的生成(P<0.05),上调E-cadherin、ZO-1表达,下调α-SMA表达,并抑制Smad2/3磷酸化;35mmol/L NAC产生类似调控作用。结论高糖腹透液可抑制PMCs细胞活性,增加ROS生成,导致PMCs EMT,其分子机制可能与ROS参与调控的Smads通路激活有关,而AS-Ⅳ可能通过减少ROS生成,抑制Smad2/3磷酸化,阻抑PMCs EMT。 OBJECTIVE To observe the effect of Astragaloside- Ⅳ(AS- Ⅳ)on oxygen stress and EMT of peritoneal mesothelial cells(PMCs)HMrSV5,explore the function of ROS in EMT and regulatory mechanism of AS-Ⅳ.METHODSWe used peritoneal dialysis solutions(PDS)with high glucose concentration to establish oxygen stress cell model of HMrSV5.Morphologic alterations of cells were observed and MTT assay was used to detect cell viability.DHE fluorescent probes were loaded to label secreted ROS.EMT-associated proteins were expressed by western blotting analysis.RESULTS 140 or 50μg/mL AS-Ⅳincreased the viability of HMrSV5(P〈0.05).Cell viability was supressed due to the longstanding effect of PDS and high glucose concentration,notably in intervention of PDS containing 4.25% glucose for 48 h.Phenotypic changes of HMrSV5 characterized by cell elongation and losing cobblestone like feature.240μg/mL AS-Ⅳcould suppress morphologic changes of cells,decrease ROS expression in model group(P〈0.05),upregulate the protein expression of E-cadherin and ZO-1 while downregulate α-SMA.Furthermore,the phosphorylation of Smad2/3protein was inhibited.3 5mmol/L NAC had the similar effect on EMT of PMCs.CONCLUSION PDS with high glucose concentration can suppress cell viability and induce EMT of PMCs by upregulating ROS expression and activation of Smads pathway.AS-Ⅳ can reduce ROS generation,suppress the phosphorylation of Smad2/3and thus,inhibite the EMT of PMCs.
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2016年第4期337-341,共5页 Journal of Nanjing University of Traditional Chinese Medicine
基金 国家自然科学基金(81473606) 江苏省中医药领军人才项目(LJ200904) 江苏省六大人才高峰项目(WS-033)
关键词 黄芪甲苷 高糖腹透液 腹膜纤维化 PMCs EMT ROS Astragaloside-Ⅳ(AS-Ⅳ) peritoneal dialysate peritoneal fibrosis EMT ROS
  • 相关文献

参考文献15

  • 1IYASERE OU,BROWN EA,JOHANSSON L,et al. Quality of life and physical function in older patients on dialysis~A compar-ison of assisted peritoneal dialysis with hemodialysis[J]. Clin J Am Soc Nephrol,2016,11(3) :423-430.
  • 2LIU J, BAO JF, HAO J, et al. HSP70 inhibits high glucose-in- duced Smad3 activation and attenuates epithelial-to-mesenchy- real transition of peritoneal mesothelial cells[J]. Mol Med Rep, 2014,10(2) : 1089-1095.
  • 3NABER HP, DRABSCH Y, SNAAR-JAGALSKA BE, et al. Snail and Slug, key regulators of TGF-~-indueed EMT, are suffi- cient for the induction of singlecell invasion[J]. Biochem Bio- phys Res Commun,2013,435(1) :58-63.
  • 4WANG LP, TIAN ZF, YANG Q, et al. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species - dependent pathway [ J ]. Oncotarget, 2015, 6 (28) : 25917-25931.
  • 5WEI JY, SHI YH, HOU YJ,et al. Knockdown of thioredoxin- interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells[J]. Cell Signal, 2013,25 = 2788-2796.
  • 6杨劲松,李正红,张旭,盛梅笑.黄芪甲苷对高糖腹膜透析液诱导人腹膜间皮细胞表达致纤维化因子的影响[J].中国中医药信息杂志,2014,21(7):36-39. 被引量:13
  • 7AROEIRA LS, AGUILERA A, SANCHEZ-TOMERO JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions[J].J Am Soc Nephrol, 2007, 18(7) :2004-2013 .
  • 8BURNS WC,THOMAS MC. The molecular mediators of type 2 epithelial to mesenchymal transition(EMT)and their role in re nal pathophysiology[J]. Expert Rev Mol Med, 2010, 12 (27) : e17.
  • 9CHANG CW,YU JC,HSIEH YH,et al. MicroRNA-30a increa- ses tight junction protein expression to suppress the epithelial- mesenchymal transition and metastasis by targeting Slug in breast caneer[J]. Oncotarget, 2016, 7 (13):16462-16478.
  • 10GOTLOIB L,WAJSBROT V,CUPERMAN Y,et al. Acute ox- idative stress induces peritoneal hyperpermeability, mesothelial loss,and fibrosis[J].J Lab Clin Med,2004,143(1):31-40.

二级参考文献20

  • 1窦献蕊,余学清,李晓艳,陈文芳,郝文科,贾占军,彭文兴,王欣,尹培达,王文健,郑智华.TGF-β1及其信号蛋白在大鼠腹膜纤维化模型腹膜组织中的表达及可能作用[J].中华医学杂志,2005,85(37):2613-2618. 被引量:22
  • 2Hung KY, Wu KD, Tsai TJ. In vitro study of peritoneal fibrosis[J]. Peritoneal Dialysis International,2007,27(S2):S72-S75.
  • 3Leung JC, Chan LY, Tam KY, et al. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis[J]. Nephrology Dialysis Transplantation,2009,24(2):458-469.
  • 4Medcalf JF, Walls J, Pawluczyk IZ, et al. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC):the role of TGF-beta[J]. Nephrology Dialysis Transplantation,2001,16(9):1885-1892.
  • 5Rougier JP, Guia S, Hagège J, et al. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures:transcriptional regulation by TGF-beta 1[J]. Kidney International, 1998,54(1):87-98.
  • 6Blom IE, van Dijk AJ, Wieten L, et al. In vitro evidence for differential involvement of CTGF, TGF-β, and PDGF-BB in mesangial response to injury[J]. Nephrology Dialysis Transplantation, 2001,16(6):1139-1148.
  • 7Holmes A, Abraham DJ, Sa S, et al. CTGF and SMADs, maintenance of scleroderma phenotype is Independent of SMAD signaling[J]. Journal of Biological Chemistry,2001,276(14):10594-10601.
  • 8Abreu JG, Ketpura NI, Reversade B, et al. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta[J]. Nature Cell Biology,2002,4(8):599-604.
  • 9Xiao L, Sun L, Liu FY, et al. Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells[J]. Therapeutic Apheresis and Dialysis,2010,14(1):27-34.
  • 10Ha H, Cha MK, Choi HN, et al. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells[J]. Peritoneal Dialysis International,2002,22(2):171-177.

共引文献21

同被引文献164

引证文献12

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部